Objectives. The aims were to assess the prevalence of malnutrition and to validate bioelectrical impedance analysis (BIA) against whole-body DXA for the assessment of body composition in patients with SSc.
methods as well as the use of different definitions. It is important to identify malnutrition in patients with SSc because it has been associated with increased morbidity and mortality [3, 4] .
The different methods used to assess malnutrition in patients with SSc have limitations. One of the most frequently used methods is the assessment of BMI, which is used either separately or in combination with the assessment of unintentional weight loss [48] . A major disadvantage of the sole use of BMI is the lack of this method to reflect deviations in body composition accurately. Deviations in body composition, for example, low fat-free mass (FFM) and high fat mass, often imply malnutrition and can exist despite a normal BMI. Therefore, the European Society for Clinical Nutrition and Metabolism (ESPEN) recently proposed a new definition of malnutrition, which includes not only measurements of underweight and weight loss, but also measurements of FFM [9] .
Different techniques are available to assess body composition. Bioelectrical impedance analysis (BIA) has several advantages over other methods [10] . It is a cheap, quick and bedside method. A weak electrical current is applied to the body to assess impedance, from which the amount of FFM is calculated by applying prediction equations. Prediction equations are available for obese and healthy persons [11] and for patients with chronic obstructive pulmonary disease. Unfortunately, these equations are not validated for patients with rheumatic diseases. An advantage of the Geneva equation is that it is validated in a population with a broad range of age and BMI [11] .
Only one earlier study reported on the use of BIA to assess body composition in patients with SSc [3] . However, it is still unknown whether BIA is a valid method to assess body composition in patients with SSc because disease-specific factors may influence impedance [11, 12] .
The aim of this study, therefore, was to assess the prevalence of malnutrition, including measurements of body composition, and to validate BIA in patients with SSc. We chose whole-body DXA as the reference method because this method is generally regarded as a gold standard for assessing body composition.
Methods

Patients
All patients with SSc who attended the outpatient department of rheumatology of the Amsterdam Rheumatology and immunology Center, location VU University Medical Center, Amsterdam, The Netherlands, between October 2013 and February 2014 were considered eligible. Patients had to fulfil the ACR criteria [13] and were subclassified as patients with lcSSc or dcSSc [14] . Patients with an overlap syndrome with another systemic rheumatic disorder were excluded. Furthermore, patients with osteosynthesis material and/or extensive calcifications and pacemakers were excluded because of possible interference with BIA. Approval by the local ethics committee, VU University Medical Center Medical Ethics Committee, was obtained, and all patients provided their written informed consent according to the Declaration of Helsinki.
Clinical assessment
Disease characteristics were systematically obtained from the medical files. Lung disease was defined as the presence of pulmonary fibrosis or interstitial lung disease on chest radiograph or high-resolution CT. Pulmonary hypertension was defined as a mean pulmonary artery pressure of 525 mmHg as assessed by right heart catheterization. Gastrointestinal tract involvement included the assessment of oesophageal dysmotility, defined as abnormal oesophageal manometry results, a clinical diagnosis by the rheumatologist or gastroenterologist, characterized by pyrosis, ructus and/or dysphagia, and/or indications of oesophageal involvement on CT. Cardiac involvement was defined as the presence of pericardial disease, the presence of conduction disturbances or arrhythmias on electrocardiography, the presence of congestive heart failure or the presence of SSc-related cardiomyopathy as assessed by MRI. Auto-antibody profile assessment included ANAs, scl-70 antibodies and centromere antibodies.
Assessment of body composition
The BIA device used in this study was the Quadscan 400 the results of serial body weight measurements, which were performed at regular intervals at the time of pulmonary function tests in the years before this study.
Statistical analysis
Statistical analysis was performed using SPSS, version 22 (SPSS Inc., Chicago, IL, USA). The prevalence of malnutrition was calculated along with its binomial 95% CI.
www.rheumatology.oxfordjournals.org student's paired t-test was used to assess equality between normally distributed data and the Wilcoxon signed ranked test in non-normally distributed data. The agreement between results of BIA and DXA measurements was assessed with BlandAltman analysis [15] and intraclass correlation coefficients. Beforehand, BIA was defined to be an acceptable method for the assessment of body composition when the systematic error did not exceed 10%, in the context of clinical relevance and applicability. Furthermore, an intraclass correlation coefficient >0.9 was considered acceptable. A value of P < 0.05 was considered statistically significant.
Results
Demographic and clinical characteristics
One hundred and twelve patients were approached to participate in this study. Eighty-seven patients gave their consent, of whom 72 patients were included. Three patients were excluded because of reactance values three times or more the S.D., which resulted in invalid body composition values. There were no differences in mean age or in the proportion of males between included and excluded patients. dcSSc was significantly less common in included patients. The demographic and clinical characteristics of the patients are shown in Table 1 .
Malnutrition
Malnutrition was present in six (8.3%) patients (95% CI: 3.0, 17.3%). Three (4.2%) patients were underweight (BMI <18.5 kg/m 2 ). Five (6.9%) patients had lost >10%
weight indefinite of time. The combination of weight loss and low FFMI was present in two patients, whereas the combination of weight loss and low BMI was present in one patient. Additionally, low FFMI was present in 15 (20.8%) patients when measured using DXA. Of these 15 patients, only 2 patients were also underweight.
Difference between BIA and DXA 
Discussion
This study demonstrates a relatively low prevalence of malnutrition in patients with SSc; however, the prevalence of low FFMI was high. To our knowledge, this is also the first study examining the validity of BIA as a method to assess body composition in patients with SSc. Malnutrition was found in 8.3% of patients, half of whom had a normal BMI. Furthermore, this study demonstrates that BIA is a valid method to assess FFM in patients with SSc on a group level, but at an individual level the FFM varies up to 4.6 kg in 95% of patients.
The prevalence of malnutrition found in our study is lower in comparison with previous studies in SSc [38] . There are several explanations for this difference. First, we used the recently proposed ESPEN definition of malnutrition, whereas most other studies used screening tools to identify patients at risk for malnutrition. In two recently published studies, the use of the ESPEN definition resulted in relatively low prevalence rates of malnutrition [16, 17] . Second, weight loss measurements were retrospectively obtained in the 3 years preceding this study. Weight loss might have occurred earlier in the disease course. Another explanation is that our study included lower percentages of patients with dcSSc. Most studies investigated a higher percentage of patients with dcSSc, reflecting a higher mean level of disease severity in their study populations [3, 5, 8] .
The prevalence of malnutrition found in our study is comparable to other chronic diseases. For example, in outpatient cohorts of middle-aged patients with RA, in Germany and Texas, malnutrition was estimated at <5% [18] . In Dutch oncology outpatients, of varying age, malnutrition was estimated at 10% [19] , while in a broad population of Dutch hospital outpatients the prevalence was 5% [19] .
Despite a relatively low prevalence of malnutrition, 20.8% of the participants had a low FFMI. This finding underlines the importance of assessing body composition in SSc patients with a standardized and validated method. We showed that BIA may be used as a method to measure body composition for research purposes in SSc. However, the value of a single BIA as a nutritional assessment method in routine clinical practice is limited.
The validity of BIA has been examined before. A systematic review of studies using different BIA devices and equations in oncology and surgery patients concluded that BIA mostly underestimated FFM (relative difference À15.2, +3.8%) [20] . Our study showed a small overestimation of FFM. Most studies describe relatively wide limits of agreements consistent with our findings. In addition, the validity of BIA depends on the chosen device and equation [20] . We used the Geneva equation because it has been validated in a broad population of healthy subjects [11] , which does not mean that this is the best equation for use in specific patient groups.
This study has several limitations. First, we recruited patients from the outpatient clinic, and most patients included had lcSSc. Also, we decided to exclude three patients with extreme reactance values. We suspect a technical error as the cause of this deviation. Consequently, the results are not applicable to all patients with SSc. Second, we did not include a control group, although we did compare our findings with other study populations.
In summary, this study evaluated the prevalence of malnutrition and validated BIA against DXA for the assessment of body composition in patients with SSc. Malnutrition was present in 8.3% of patients with SSc, and BIA is a suitable device for the assessment of body composition in patients with SSc at a group level, but caution should be exercised when using BIA in an individual patient to assess malnutrition.
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